Projections for the influenza vaccines market suggest remarkable growth, anticipating an increase to $9.66 billion by 2033. This projection indicates a compound annual growth rate (CAGR) of approximately 8% from 2025 to 2033.
The United States Influenza Vaccines market size was valued at USD 4.78 Billion in 2024 and is expected to grow USD 9.66 Billion in 2033 at a compound annual growth rate (CAGR) of 8% from 2025 to 2033.
